- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/08 - IndolesHydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/08
Total number of patents in this class: 1280
10-year publication summary
97
|
101
|
97
|
88
|
84
|
77
|
58
|
84
|
70
|
34
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19918 |
15 |
Vertex Pharmaceuticals Incorporated | 1597 |
15 |
F. Hoffmann-La Roche AG | 7925 |
13 |
Abbvie Inc. | 1800 |
13 |
Astellas Pharma Inc. | 1088 |
12 |
Novartis AG | 10849 |
11 |
Bristol-myers Squibb Company | 4898 |
10 |
LG Chem, Ltd. | 17632 |
10 |
Illumina Cambridge Limited | 679 |
10 |
University of Tennessee Research Foundation | 758 |
10 |
Merck Patent GmbH | 5831 |
9 |
Board of Regents, The University of Texas System | 5793 |
9 |
The Wistar Institute of Anatomy and Biology | 450 |
9 |
Allergan, Inc. | 2349 |
8 |
Glaxosmithkline Intellectual Property (no.2) Limited | 288 |
8 |
Supernus Pharmaceuticals, Inc. | 137 |
8 |
Samsung Display Co., Ltd. | 34696 |
7 |
Boehringer Ingelheim International GmbH | 4650 |
7 |
Janssen Pharmaceutica N.V. | 3392 |
7 |
Centre National de La Recherche Scientifique | 10418 |
7 |
Other owners | 1082 |